Ezel Berker

Ezel Berker

Auto-generated profile, based on publicly available information

Ezel Berker

HACETTEPE ÜNİVERSİTESİ, DİŞ HEKİMLİĞİ FAKÜLTESİ, KLİNİK BİLİMLER BÖLÜMÜ, PERİODONTOLOJİ ANABİLİM DALI

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
DGDeniz Can Guven
Deniz Can Guven
ÖDÖmer Dizdar
Ömer Dizdar
AAAbdullah Cevdet Akman
Abdullah Cevdet Akman
EBEzel Berker
Ezel Berker
EYEmre Yekedüz
Emre Yekedüz
MHMutlu Hayran
Mutlu Hayran
In this study, we aimed to assess the cancer risk among patients with periodontal disease. Patients diagnosed with periodontal diseases at Hacettepe University between 2007 and 2012 were included and data on the diagnosis of any cancer after periodontal disease were collected from patient files. The age- and sex-standardized incidence rates (SIRs) were calculated using Turkish National Cancer Registry 2013 data. A total of 5199 patients were included. Median follow-up was 7.2 years. Patients with periodontal diseases had 17% increased risk of cancer compared with the expected counts for the corresponding age and sex groups (SIR: 1.17; 95% CI: 1.04–1.3, P = 0.006). The increased cancer risk was statistically significant in women (SIR: 1.24; 95% CI: 1.05–1.45, P = 0.008) but not in men. Among women with periodontal disease, the risks of breast cancer (SIR: 2.19) and head and neck cancer (SIR: 4.71) were significantly increased. Among men, the risks of prostate cancer (SIR: 1.84), head and neck cancer (SIR: 3.55), and hematological cancers (SIR: 1.76) were significantly increased. This study showed that periodontal diseases were associated with increased risk of several cancers. Besides other well-known benefits for health, the provision of oral/dental health should be considered and employed as a cancer prevention measure.

30 June 2025 in Clinical and Experimental Health Sciences
Verified
Journal Article
Closed access
PDF file
SKSelva Keşir
Selva Keşir
EOEbru Olgun
Ebru Olgun
ÜKÜçler Kısa
Üçler Kısa
EBEzel Berker
Ezel Berker
Objective: The role of proinflammatory cytokines in chronic periodontitis (P) and coronary artery diseases (CAD) is currently under investigation. Interleukin 17 (IL 17) may play a role in the bidirectional pathogenesis of both conditions. The aim of the study is to explore the effect of non-surgical periodontal therapy on the gingival crevicular fluid (GCF) and serum levels of IL 17 in stable CAD patients with P. Methods: Sixty-one individuals were enrolled in the study including 32 chronic periodontitis [16 periodontitis (CAD-P+), 16 coronary artery disease with periodontitis (CAD+P+)] and 29 periodontally healthy subjects [15 (CAD-P-) and 14 patients with coronary artery disease (CAD+P-)]. GCF and serum samples were obtained and probing pocket depth (PPD), clinical attachment level (CAL), plaque index (PI) and gingival index (GI) were recorded at baseline and three months post-treatment. GCF and serum IL 17 levels were analyzed by enzyme-linked immunosorbent assay (ELISA). Results: We observed significant improvements in the whole mouth and sample tooth periodontal parameters (both with p < .001) and as well as a reduction in GCF volume (p < .05) following periodontal treatment in periodontitis groups (CAD-P+ and CAD+P+). Serum IL 17 levels significantly decreased in CAD+P+ group following the periodontal therapy (baseline: 24.39 (13.04) pg/ml; 3rd month 19.16 (15.07) pg/ml, p < .05) while no significant alterations were observed in GCF samples. Conclusion: IL 17 is linked to proinflammatory response in atherosclerosis. Its post-treatment decrease in CAD+P+ group suggests IL 17 might be a useful biomarker for CAD-periodontitis relationship.